title: Gefitinib therapy for life-threatening laryngeal papillomatosis.
authors.affiliation: Division of Pediatric Hematology Oncology, Children's Hospitals and Clinics, Minneapolis, MN 55455, USA. Bruce.Bostrom@childrenshc.org
authors.forename: Bruce
authors.initials: B
authors.lastname: Bostrom
authors.forename: James
authors.initials: J
authors.lastname: Sidman
authors.forename: Stephen
authors.initials: S
authors.lastname: Marker
authors.forename: Timothy
authors.initials: T
authors.lastname: Lander
authors.forename: Dennis
authors.initials: D
authors.lastname: Drehner
mesh_terms: D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use; D001999:Bronchoscopy; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000077156:Gefitinib; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy* / Q000601:surgery / Q000821:virology; D008297:Male; D010212:Papilloma / Q000188:drug therapy* / Q000601:surgery / Q000821:virology; D030361:Papillomavirus Infections / Q000150:complications*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib